Cryo-Cell International (NYSE: CCEL) schedules 2025 annual shareholder meeting

Rhea-AI Filing Summary

Cryo-Cell International, Inc. has scheduled its 2025 Annual Meeting of Stockholders for October 21, 2025. The company set September 15, 2025 as the record date, which means only stockholders of record on that date will be entitled to receive notice of and vote at the meeting.

Stockholders who want to present business or nominate directors at the Annual Meeting must deliver the required notice under the Company’s Bylaws no later than the 10th calendar day after public disclosure of the meeting date, which occurred on September 10, 2025.

0000862692false00008626922025-09-082025-09-08

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): September 08, 2025

CRYO-CELL INTERNATIONAL, INC.

(Exact name of Registrant as Specified in Its Charter)

Delaware			001-40767	22-3023093
(State or Other Jurisdiction of Incorporation)			(Commission File Number)	(IRS Employer Identification No.)
700 Brooker Creek Blvd. Suite 1800
Oldsmar, Florida				34677
(Address of Principal Executive Offices)				(Zip Code)

Registrant’s Telephone Number, Including Area Code: 813 749-2100

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, $0.01 par value		CCEL		NYSE American LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 8.01 Other Events.

The Board of Directors of the Company has fixed October 21, 2025 as the date for the 2025 Annual Meeting of Stockholders of the Company (the “Annual Meeting”), and has fixed September 15, 2025 as the record date for determining stockholders entitled to notice of and to vote at the Annual Meeting. Stockholders intending to present business or director nominations at the Annual Meeting must submit the notice required by Article II, Section 3 of the Company’s Bylaws (with respect to business other than director nominations) or Article II, Section 10 of the Company’s Bylaws (with respect to director nominations) no later than the 10th calendar day following the day on which public disclosure of the date of the Annual Meeting is first made, which date of public disclosure is September 10, 2025.

A copy of the Company’s Bylaws, as amended, is included as Exhibit 3.1 to the Current Report on Form 8-K filed with the United States Securities and Exchange Commission on December 11, 2018.

.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

			Cryo-Cell International, Inc.
Date:	September 10, 2025	By:	/s/ David Portnoy
			David Portnoy, Chairman and Co-CEO

FAQ

When is Cryo-Cell International (CCEL) holding its 2025 Annual Meeting?

The 2025 Annual Meeting of Stockholders of Cryo-Cell International, Inc. is scheduled for October 21, 2025.

What is the record date for Cryo-Cell International (CCEL) 2025 Annual Meeting?

The record date for determining stockholders entitled to notice of and to vote at the 2025 Annual Meeting is September 15, 2025.

Who is entitled to vote at Cryo-Cell International’s 2025 Annual Meeting?

Stockholders of Cryo-Cell International, Inc. who are on the company’s records as of September 15, 2025 are entitled to receive notice of and vote at the 2025 Annual Meeting.

What is the deadline for stockholder proposals or director nominations for CCEL’s 2025 Annual Meeting?

Stockholders must submit notices for business or director nominations no later than the 10th calendar day following the day on which public disclosure of the Annual Meeting date was first made, which disclosure date is September 10, 2025.

Which bylaws govern stockholder business and director nominations at Cryo-Cell’s 2025 Annual Meeting?

Business other than director nominations is governed by Article II, Section 3 of the Company’s Bylaws, and director nominations are governed by Article II, Section 10 of the Bylaws.

Where can investors find Cryo-Cell International’s current bylaws?

A copy of the Company’s Bylaws, as amended, is included as Exhibit 3.1 to a filing made on December 11, 2018.